You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
| Title |
Is a high-risk clinical target volume required? Evaluation of the dosimetric feasibility based on T staging
|
|---|---|
| Published in |
Frontiers in oncology, September 2022
|
| DOI | 10.3389/fonc.2022.800400 |
| Pubmed ID | |
| Authors |
Xingxing Yuan, Chao Yan, Shiyi Peng, Zhiping Chen, Tianzhu Lu, Qiaoying Gong, Yang Qiu, Wenming Xiong, Fenghua Ao, Guoqing Li, Jingao Li, Ziwei Tu |